Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2019-05-30, Stock:PFE, The news for the past five days is as follows:
2019-05-22: NEWS1: Health Care Sector Update for 05/22/2019: OBLN, CODX, AFMD, JNJ, PFE, ABT, MRK, AMGN.NEWS2: Health Care Sector Update for 05/22/2019: OBLN, CODX, AFMD, JNJ, PFE, ABT, MRK, AMGN.NEWS3: Ocular's Glaucoma Drug Study Fails to Meet Primary Endpoint.NEWS4: Ocular's Glaucoma Drug Study Fails to Meet Primary Endpoint.
2019-05-23: NEWS1: Greenwich Capital Commercial Funding Corp., 2005-GG3 -- Moody's affirms two and downgrades one class of GCCFC 2005-GG3.NEWS2: Next level of support for Pioneer? Pfizer or J&J? The viewers #AskHalftime.NEWS3: Alphabet to Aid Pharma Giants Enhance Clinical Trial Process.NEWS4: Alphabet to Aid Pharma Giants Enhance Clinical Trial Process.NEWS5: Lilly (LLY) Launches Half-Priced Version of Humalog Insulin.NEWS6: Lilly (LLY) Launches Half-Priced Version of Humalog Insulin.NEWS7: Alphabet to Aid Pharma Giants Enhance Clinical Trial Process.NEWS8: Health Care Sector Update for 05/23/2019: NVCN, IOVA, MDT, JNJ, PFE, ABT, MRK, AMGN.NEWS9: Health Care Sector Update for 05/23/2019: NVCN, IOVA, MDT, JNJ, PFE, ABT, MRK, AMGN.NEWS10: Johnson & Johnson (JNJ) Ex-Dividend Date Scheduled for May 24, 2019.NEWS11: Johnson & Johnson (JNJ) Ex-Dividend Date Scheduled for May 24, 2019.NEWS12: Lilly (LLY) Launches Half-Priced Version of Humalog Insulin.
2019-05-24: NEWS1: Pfizer&apos;s Lyrica doesn&apos;t meet endpoint in epilepsy study.NEWS2: Pfizer Announces Top-Line Results from Phase 3 Trial of LYRICA® (pregabalin) in Primary Generalized Tonic-Clonic Seizures.NEWS3: Barrow, Hanley, Mewhinney & Strauss Trims Multiple Positions in 1st Quarter.NEWS4: 3 Stocks to Win Big in the Fight Against Cancer.NEWS5: 3 Stocks to Win Big in the Fight Against Cancer.NEWS6: 3 Stocks to Win Big in the Fight Against Cancer.
2019-05-28: NEWS1: 4 Drug and Health Stocks Pushing Higher &#160;.NEWS2: 4 Drug and Health Stocks Pushing Higher &#160;.NEWS3: A hemophilia patient hero at zero, BioMarin to seek FDA OK for gene therapy. But will the effect last?.NEWS4: This Just In: Goldman Sachs Picks 4 Big Pharma Stocks to Buy.NEWS5: This Just In: Goldman Sachs Picks 4 Big Pharma Stocks to Buy.NEWS6: J.P. Morgan Chase Commercial Mortgage Securities Trust 2019-OSB -- Moody's assigns provisional ratings to six CMBS classes of J.P. Morgan Chase Commercial Mortgage Securities Trust 2019-OSB.NEWS7: This Just In: Goldman Sachs Picks 4 Big Pharma Stocks to Buy.NEWS8: 4 Drug and Health Stocks Pushing Higher.NEWS9: Conatus Down More Than 60% in the Past 90 Days: Here's Why.NEWS10: Conatus Down More Than 60% in the Past 90 Days: Here's Why.NEWS11: Notable ETF Inflow Detected - VLUE, T, PFE, BAC.NEWS12: Notable ETF Inflow Detected - VLUE, T, PFE, BAC.NEWS13: Conatus Down More Than 60% in the Past 90 Days: Here's Why.NEWS14: British Columbia to be first Canadian province to switch patients to biosimilars.NEWS15: Health Care Sector Update for 05/28/2019: TRXC, QTNT, BMRN, JNJ, PFE, ABT, MRK, AMGN.NEWS16: Health Care Sector Update for 05/28/2019: TRXC, QTNT, BMRN, JNJ, PFE, ABT, MRK, AMGN.NEWS17: The Zacks Analyst Blog Highlights: Guardant, Illumina, Exact Sciences and Pfizer.NEWS18: Here are the biggest analyst calls of the day: Beyond Meat, Apple, Southwest, Pfizer, Roku & more.NEWS19: See what the IHS Markit Score report has to say about Pfizer Inc..
2019-05-29: NEWS1: J.P. Morgan Chase Commercial Mortgage Securities Trust 2019-OSB -- Moody's assigns a provisional rating to One CMBS class of J.P. Morgan Chase Commercial Mortgage Securities Trust 2019-OSB.NEWS2: Merck (MRK) Up This Year So Far: Will the Momentum Continue?.NEWS3: Merck (MRK) Up This Year So Far: Will the Momentum Continue?.NEWS4: After Hours Most Active for May 29, 2019 :  ELAN, PFE, QD, LC, TVPT, KO.NEWS5: After Hours Most Active for May 29, 2019 :  ELAN, PFE, QD, LC, TVPT, KO.NEWS6: 5 Pharmaceutical Stocks With Big Moats and Bridges.NEWS7: Merck (MRK) Up This Year So Far: Will the Momentum Continue?.NEWS8: Lilly In-Licenses Private Biotech's Non-Opoid Pain Candidate.NEWS9: Lilly In-Licenses Private Biotech's Non-Opoid Pain Candidate.NEWS10: Dow Analyst Moves: PFE.NEWS11: Dow Analyst Moves: PFE.NEWS12: Lilly In-Licenses Private Biotech's Non-Opoid Pain Candidate.NEWS13: Health Care Sector Update for 05/29/2019: SOLY, CARA, FCSC, JNJ, PFE, ABT, MRK, AMGN.NEWS14: Health Care Sector Update for 05/29/2019: SOLY, CARA, FCSC, JNJ, PFE, ABT, MRK, AMGN.NEWS15: Pro-choice groups lost in Alabama despite outspending the pro-life side by 100-to-1.NEWS16: Perrigo Company (PRGO) Ex-Dividend Date Scheduled for May 30, 2019.NEWS17: Perrigo Company (PRGO) Ex-Dividend Date Scheduled for May 30, 2019.

Answer: Rise